Japanese IT Stock News

Recent share performance and business scale Takeda Pharmaceutical (TSE:4502) has drawn investor attention after a recent pullback, with the stock showing a 1.8% decline over the past day and about a 10% decline over the past month. Over the past 3 months the share price shows about a 5.5% decline, while the 1 year total return stands at 28.2%, the 3 year total return at 32.9%, and the 5 year total return at about 7.4x. At the last close of ¥5,213, Takeda’s market value stands at about ¥8.2t,...

Investors may be wondering if Sumitomo at ¥7,180 is still reasonably priced after such a strong run, or if the stock is already reflecting most of the good news. The stock has delivered returns of 5.0% over the last week, 14.8% over the last month, 28.9% year to date and 102.7% over the last year, with a multiyear gain that is very large. Recent news coverage has focused on Sumitomo as a key player within Japan's capital goods sector, highlighting how investors are paying close attention to...

If you are wondering whether Tokio Marine Holdings at ¥7,030 offers good value today, it helps to step back and look at what recent returns and current pricing might be telling you about expectations baked into the stock. The stock is up 18.9% year to date and 24.6% over the last 12 months, even after a 0.9% decline over the past week and a 4.6% decline over the last month, which can shift how investors think about both upside potential and downside risk. Recent news coverage has focused on...

In early May 2026, Olympus Corporation announced an exclusive global distribution agreement with EndoRobotics to add robot-assisted endoscopic technologies to its EndoTherapy portfolio, aiming to broaden access to minimally invasive treatments for early-stage gastrointestinal cancers and precancerous lesions worldwide. This move underscores Olympus’ push into endoluminal robotics, where combining its global commercial reach with EndoRobotics’ precision tools could meaningfully influence how...

If you are wondering whether ROHM is still attractively priced after its recent run, you are not alone. The numbers give plenty to think about. The stock last closed at ¥3,899, with returns of 11.8% over 7 days, 7.4% over 30 days, 71.2% year to date and 191.5% over 1 year. This has put recent valuation questions front and center for many investors. Recent coverage around ROHM has focused on its role in the semiconductor sector and how investor sentiment is responding to that positioning...

Ajinomoto (TSE:2802) recently reported full year results to March 31, 2026, with sales of ¥1,583,719 million and net income of ¥134,675 million, alongside higher basic earnings per share versus the prior year. See our latest analysis for Ajinomoto. The stock has been strong over multiple timeframes, with a 22.71% 90 day share price return and a 57.05% 1 year total shareholder return, which aligns with improving earnings and investor confidence in the latest results. If Ajinomoto's move has...

With the business potentially at an important milestone, we thought we'd take a closer look at QD Laser, Inc.'s...

If you are wondering whether NEC at ¥4,200 is offering good value today, it helps to first line up the recent share performance with how the stock is currently priced. The stock has returned 4.1% over the last week and 0.3% over the last month, while year to date it is down 22.7% and the 1 year return sits at 12.6%, with a very large gain over 3 years and a 333.9% return over 5 years. These moves sit against a backdrop of ongoing coverage of NEC's role in software and IT solutions, along...

Wondering whether Sumitomo Metal Mining is still reasonably priced after a strong run, or if the stock has moved ahead of its underlying value? The share price last closed at ¥10,615, alongside returns of 11.4% over 7 days, 2.5% over 30 days, 59.9% year to date, 246.0% over 1 year, 164.7% over 3 years and 159.8% over 5 years. Recent coverage has focused on how these share price moves relate to the broader metals and mining theme and shifting sentiment toward resource companies. Headlines...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

The market seemed underwhelmed by last week's earnings announcement from Otsuka Corporation ( TSE:4768 ) despite the...

Last week's profit announcement from Marubeni Corporation ( TSE:8002 ) was underwhelming for investors, despite...

Investors may be wondering whether KDDI is fairly priced or offering hidden value right now, especially after its recent share price moves. The stock last closed at ¥2,528.5, with returns of a 0.8% decline over 7 days, 6.7% decline over 30 days, 7.5% decline year to date, 2.0% decline over 1 year, 25.6% over 3 years, and 67.4% over 5 years. Taken together, this provides a mixed picture of recent pressure and longer term strength. Recent attention on KDDI has focused on how its share price...

If you are wondering whether ASICS stock still offers value after its strong run, or if you might be late to the story, this article breaks down what the current price could be implying. The stock last closed at ¥4,640, with returns of 6.9% over 7 days, 4.7% over 30 days, 20.6% year to date and 40.7% over 1 year, while the 3 year return is very large and the 5 year return is close to 8x. Recent coverage has focused on ASICS as a long term compounder in the athletic footwear space. Attention...

Niterra Co., Ltd. has released its full-year results for the period ended March 31, 2026, reporting sales of ¥731,207 million, net income of ¥112,892 million, and basic earnings per share from continuing operations of ¥570.43. These figures give investors an updated view of Niterra’s overall scale and profitability as the company closes its latest fiscal year. We will now look at how Niterra’s full-year profitability profile shapes the company’s investment narrative and future...

Rakuten Group (TSE:4755) is backing Swarmer, Inc.'s autonomy solutions in Japan’s advanced unmanned systems sector. The company is linking this support with its ongoing humanitarian engagement and technology ties in Ukraine. The move connects Rakuten’s digital capabilities with robotics and autonomy projects in Japan’s manufacturing and infrastructure fields. For you as an investor, this places Rakuten Group’s core digital and platform business alongside a more hardware-focused field:...

Unicharm Corporation recently held its Q1 2026 earnings call on May 8, following its scheduled earnings announcement for early May. Investor attention has centered on Unicharm’s strong balance sheet, with very low debt-to-equity and solid liquidity underpinning confidence ahead of results. With Unicharm’s robust balance sheet in focus, we’ll now examine how this earnings update shapes the company’s broader investment narrative. Find 15 companies with promising cash flow potential yet trading...

For readers wondering whether Renesas Electronics at ¥3,623 is still attractively priced or already running ahead of itself, this article breaks down what the current share price might be implying about value. The stock has posted returns of 12.8% over the last week, 56.7% over the last month, 62.8% year to date, and 114.3% over the past year, which may signal that expectations or perceived risks have shifted meaningfully. Recent coverage has focused on Renesas Electronics in the context of...

Cawachi Limited's ( TSE:2664 ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

The market for Tokyo Electron Limited's ( TSE:8035 ) stock was strong after it released a healthy earnings report last...

In April 2026, Komatsu Ltd. announced it would repurchase up to 25,000,000 shares for ¥100,000 million, cancel the repurchased stock, reported full-year 2026 earnings of ¥4,132,751 million in sales and ¥376,391 million in net income, and issued guidance and dividend plans for fiscal 2027. This combination of a sizeable cancellation-backed buyback and detailed earnings and dividend outlook provides fresh insight into how Komatsu is balancing capital returns with reinvestment needs. We will...

Earlier this month, Takeda Pharmaceutical reported that its pivotal Phase 2/3 trial of investigational PID therapy TAK-881 met its primary pharmacokinetic endpoint, showing comparable IgG exposure, efficacy and safety to HYQVIA, while potentially allowing patients to receive equivalent immunoglobulin doses in roughly half the infusion volume. Because TAK-881 may offer shorter, lower-volume infusions with once-monthly flexibility, it could meaningfully change treatment convenience for Primary...

Earnings and dividend review put Shin-Etsu PolymerLtd (TSE:7970) in focus Shin-Etsu PolymerLtd (TSE:7970) has just reported full year results to March 31, 2026 and held a board meeting to consider revising its dividend forecast, putting earnings quality and shareholder returns under closer investor scrutiny. See our latest analysis for Shin-Etsu PolymerLtd. The recent earnings announcement and board meeting on the dividend forecast came against a strong backdrop, with Shin-Etsu PolymerLtd’s...

What Shiseido’s New Bond Shelf Could Mean for the Stock Shiseido Company (TSE:4911) has filed a shelf registration to issue up to ¥300 billion in bonds, a move that gives the company flexibility to raise debt funding when conditions appear favorable. For you as a shareholder or potential investor, this filing matters because it may influence Shiseido’s future capital structure, interest costs, and capacity to fund projects, acquisitions, or balance sheet adjustments, without immediately...